Background: In order to manage bacterial infections in hospitals in the face of antibiotic resistance, the two treatment protocols "mixing" and "cycling" have received considerable attention both from modelers and clinicians. However, the terms are not used in exactly the same way by both groups.
Introduction
With bacteria evolving resistance, potent drugs turn ineffective against bacterial infections. Evolution of resistance to a single antibiotic is often rapid, calling for treatment strategies that involve the employment of more than one drug. Besides the simultaneous prescription of a combination of antibiotics to a single patient, several antibiotics belonging to different classes can be used across a community in order to manage the spread of resistance at a population level. This is particularly feasible within a hospital, where drug usage can be controlled and coordinated. Two generic strategies -cycling and mixing of antibioticshave attracted considerable attention for the phase of empirical therapy. [1] [2] [3] With cycling, drug A and drug B get alternated. With mixing, one half of all patients receive drug A and the other half drug B. Both strategies increase heterogeneity in selection. Assessing the usefulness of these control measures by means of clinical trials is crucial but inherently difficult. While the number of empirical studies is increasing, the overall picture remains inconclusive. [4] [5] [6] [7] [8] Mathematical models therefore remain a helpful tool in understanding which strategy is more promising. 1, 2, [9] [10] [11] [12] [13] [14] [15] [16] [17] ). It turns out that the verbal description of this implementation is easily misinterpreted. In particular, it differs from empirical practice.
The overall modeling approach taken in all studies is a type of epidemic model with transmission between patients, where infected patients are divided up into several compartments according to the infecting bacterial strain. The traditional implementation of treatment protocols neglects the dynamics that arise if the perspective of individual patients is taken into account. For cycling, this means that when the time for a switch of the drug has come, a patient who is already treated gets switched to another antibiotic rather than that the new drug is only applied to newly infecteds. For mixing, it means that in every compartment at any time, one half of all patients are treated with drug A and the other half with drug B. Importantly, this is not the same as prescribing a random drug to every patient upon infection. To see this, imagine a patient who is infected with a bacterial strain resistant to drug A. Drug B successfully suppresses the infection, leading to a fast recovery. In contrast, drug A is ineffective and the patient recovers slowly. As a consequence, the fraction of patients that get treated with drug A among all those that are infected with an A-resistant strain quickly rises to more than 50% even if newly infecteds have a 50-50 chance to get treated with drug B. The common modeling approach probably comes closest to a situation where at every drug intake, patients take a random drug (although this would have effects at the within-host level that are not captured by the models).
In this article, we set up an alternative model where cycling and mixing refer to the individual antibiotic prescription. We demonstrate by means of examples that this can lead to qualitatively different predictions.
Methods
We use a model for the spread of bacterial infections in a hospital that is based on a mix of the models in Bonhoeffer et al. (1997) and Bergstrom et al. (2004) . 1, 2 Patients can be uninfected or infected with one of four bacterial strains and can either be already infected at hospitalization or acquire the infection from other patients within the hospital. Resistance can be brought into the hospital from the outside or arise de-novo.
We denote the number of uninfected individuals by X. Patients that are infected by the sensitive or a resistant strain are denoted by S and R • , respectively, and the subscript indicates to which antibiotic(s) the strain is resistant. Patients enter the hospital at a total rate of n tot µ and leave at a per-capita rate of µ independently of infectious status. In other words, the model assumes that the infection does not increase mortality, and that the infection is not the cause for the hospitalization. m • is the fraction of incoming patients for the respective compartment. The transmission probability between uninfecteds and infected patients carrying the sensitive strain is given by β. The transmission probability is reduced by a factor (1 − c • ) for infection with a resistant strain; this accounts for a cost of resistance. If a patient infected with a strain sensitive to the currently applied drug gets infected by a resistant strain, the resistant strain can replace the sensitive strain. This happens with a lower probability than infection of an uncolonized patient (reduction by a factor σ). Independently of treatment, the immune response of patients leads to recovery at rate γ. Treatment with a working drug leads to recovery at rate τ . Finally, bacteria can evolve resistance. During treatment with drug A/B, resistance evolves at rate ν A /ν B . Additionally, the sensitive strain becomes resistant to both drugs within a single step at rate ν AB .
In the traditional model, a fraction χ A is treated with drug A and a fraction 1 − χ A with drug B in every compartment at any time. Overall, we obtain the following set of differential equations:
For the alternative model, we split up the compartments S, R A , and R B according to the treatment that patients receive. 13, 15 The drug is indicated by a superscript. E.g. R (A) A denotes the number of all patients that are infected by a strain resistant to drug A and that are treated with drug A. χ A is now the fraction of patients who receive drug A throughout the entire course of their therapy. This yields:
(2)
We numerically integrate Eq. (1) and Eq. (2) 
Results and Discussion
We consider two complementary scenarios.
Absence of double resistance. The de-novo emergence of resistance within the hospital can be neglected (ν A = ν B = ν AB = 0), and no double resistant cases are admitted to the hospital (m AB = 0). This corresponds to the situation considered in Bergstrom et al.
(2004) 2 and we use the same parameter set; cf. also the similar "Case III" in Bonhoeffer et al. (1997) . 1 We assess the success of the respective strategy by the number of uninfected patients (Figure 1) . For both strategies, the number of uninfected patients is lower in the alternative than in the traditional model, since the latter essentially exposes a fraction of patients to both drugs during the course of treatment. Figure 1C shows that in the standard model, cycling performs worse than mixing for all cycling periods, 2 whilst in the alternative model, we find an optimal cycling frequency around which cycling is slightly better than mixing (cf. also Panels A and B). In this regime, a large fraction of new infections is caused by patients who get still treated with the previous drug and carry the corresponding resistant strain; these new infections are now successfully treated. A similar result as in Figure 1C has been found before in a more complex model, where it was attributed to drug adjustment in case of resistance. 15
De-novo emergence of resistance within the hospital. There is no influx of patients harbouring resistant bacteria (m A = m B = m AB = 0), and all resistance emerges de-novo within the hospital (cf. "Case II" in Bonhoeffer et al. (1997) 1 ). We now consider the spread of double resistance. The picture is essentially the reverse of the medal from the previous paragraph. In the new model, the number of patients infected by a single resistant strain rises to high numbers under the mixing strategy since patients that get treated with an ineffective drug only recover very slowly. At the same time, the colonizing strain is not confronted with the other drug until a new patient gets infected and treated with the second drug. The selection pressure for the double resistant strain is hence low and the spread of double resistance is delayed compared to the standard model (cf. upper and lower Panels in Figure 2 ). The dynamics under cycling converge to those under mixing for rapid cycling ( Figure 2C and F). For slow cycling, the spread of double resistance in the two models is more similar (Panels A and D). For intermediate cycling (Panels B and E), the prediction under which treatment strategy the double resistant strain spreads faster gets reversed.
Conclusions. The terms "mixing" and "cycling" do not refer to the same protocol in mathematical standard models and in clinical practice, the former neglecting the behavior of individual patients. In large parts of the parameter space, the results from the standard model and the alternative model that comes closer to the real-life implementation are qualitatively -and sometimes even quantitatively -similar. However, the examples given in this article show that they can also lead to different conclusions, e.g. with the new model, the number of uninfected patients can be lower under cycling than under mixing, where the standard model predicts the opposite. Given such important discrepancies, it seems to be time to be more critical about the established model simplification. 
